We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$5.99B
AUM Growth
+$203M
Cap. Flow
+$168M
Cap. Flow %
2.8%
Top 10 Hldgs %
39.68%
Holding
189
New
63
Increased
26
Reduced
35
Closed
53

Top Sells

Rank Stock Value
1
BILL icon
BILL Holdings
BILL
+$177M
2
MSFT icon
Microsoft
MSFT
+$159M
3
ADI icon
Analog Devices
ADI
+$155M
4
WIX icon
WIX.com
WIX
+$149M
5
NFLX icon
Netflix
NFLX
+$149M

Sector Composition

Rank Sector Weight
1 Technology 25.93%
2 Consumer Discretionary 9.83%
3 Communication Services 8.66%
4 Healthcare 7.99%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXE
76
Expand Energy Corp
EXE
$22B
$10.8M 0.18%
+175,418
New +$9.83M
PRCT icon
77
Procept Biorobotics
PRCT
$1.02B
$10.5M 0.18%
+274,960
New +$10.6M
OGN icon
78
Organon & Co
OGN
$3.56B
$10.3M 0.17%
315,000
-38,000
-11% -$1.22M
CNC icon
79
Centene
CNC
$31.3B
$10.3M 0.17%
165,000
-404,397
-71% -$27M
XLV icon
80
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$10.2M 0.17%
+80,507
New +$10.6M
MEOH icon
81
Methanex
MEOH
$4.01B
$10.1M 0.17%
+219,017
New +$7.91M
ABT icon
82
Abbott
ABT
$190B
$10M 0.17%
85,000
-90,000
-51% -$11.1M
ZBH icon
83
Zimmer Biomet
ZBH
$18.7B
$9.63M 0.16%
+67,774
New +$9.97M
FYBR
84
DELISTED
Frontier Communications
FYBR
$9.51M 0.16%
+341,381
New +$10.2M
RXRX icon
85
Recursion Pharmaceuticals
RXRX
$1.59B
$9.42M 0.16%
409,567
-3,405
-0.8% -$96.5K
CANO
86
DELISTED
Cano Health, Inc.
CANO
$9.34M 0.16%
7,362
-26,861
-78% -$32.6M
LLY icon
87
Eli Lilly
LLY
$1.09T
$9.24M 0.15%
40,000
-21,000
-34% -$5.18M
ELAN icon
88
Elanco Animal Health
ELAN
$12.8B
$8.84M 0.15%
277,300
-3,000
-1% -$101K
ENOV icon
89
Enovis
ENOV
$1.7B
$8.77M 0.15%
+111,010
New +$8.92M
HYG icon
90
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.8B
$8.75M 0.15%
+100,000
New +$8.77M
XLRN
91
CALL
DELISTED
Acceleron Pharma
XLRN
$8.61M 0.14%
+50,000
New +$6.54M
GSK icon
92
GSK
GSK
$106B
$7.97M 0.13%
166,800
+30,000
+22% +$1.51M
QGEN icon
93
Qiagen
QGEN
$8.68B
$7.42M 0.12%
135,347
-173,032
-56% -$9.63M
BSX icon
94
Boston Scientific
BSX
$68.4B
$7.38M 0.12%
+170,000
New +$7.52M
EW icon
95
Edwards Lifesciences
EW
$48.9B
$7.36M 0.12%
65,000
-5,000
-7% -$571K
BAX icon
96
Baxter International
BAX
$12.8B
$7.24M 0.12%
+90,000
New +$7.11M
THC icon
97
Tenet Healthcare
THC
$22.3B
$6.64M 0.11%
100,000
+25,000
+33% +$1.77M
PFE icon
98
CALL
Pfizer
PFE
$144B
$6.45M 0.11%
150,000
-50,000
-25% -$2.22M
UNH icon
99
PUT
UnitedHealth
UNH
$387B
$5.86M 0.1%
+15,000
New +$6.21M
INTC icon
100
Intel
INTC
$425B
$5.33M 0.09%
100,000
+10,000
+11% +$542K

Similar funds

PointState Capital's Q3 2021 Portfolio in Review

As of Q3 2021, PointState Capital held 189 positions worth $5.99B, up 3.5% from $5.79B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

PointState Capital's Q3 2021 filing shows 63 new, 26 increased, 35 reduced and 53 closed positions. Its largest new stake was Booking.com: 1,324,875 shares worth $126M. The largest sale was BILL Holdings, an estimated $177M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • PointState Capital's largest Q3 2021 buy was Booking.com: 1,324,875 shares worth $126M.
  • PointState Capital added most to Meta Platforms (Facebook) in Q3 2021, an estimated $222M increase.
  • PointState Capital's biggest Q3 2021 reduction was BILL Holdings, cutting an estimated $177M.
  • PointState Capital fully exited Analog Devices in Q3 2021, selling an estimated $155M.
  • PointState Capital's ten largest holdings make up 40% of its $5.99B portfolio in Q3 2021.
  • PointState Capital opened 63 new positions and closed 53 in Q3 2021.
  • PointState Capital's portfolio value rose 3.5% quarter-over-quarter to $5.99B.

Based on PointState Capital's 13F filing for Q3 2021, filed 15 Nov 2021.